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Abstract
Metastasis to a variety of distant organs, such as lung, brain, bone, and liver, is a leading cause of mortality in the breast
cancer patients. The tissue tropism of breast cancer metastasis has been recognized and studied extensively, but the cellular
processes underlying this phenomenon, remain elusive. Modern technologies have enabled the discovery of a number of
the genetic factors determining tissue tropism of malignant cells. However, the effect of these genetic differences on the
cell motility and invasiveness is poorly understood. Here, we report that cellular responses to the mechanical rigidity of the
extracellular matrix correlate with the rigidity of the target tissue. We tested a series of single cell populations isolated from
MDA-MB-231 breast cancer cell line in a variety of assays where the extracellular matrix rigidity was varied to mimic the
environment that these cells might encounter in vivo. There was increased proliferation and migration through the matrices
of rigidities corresponding to the native rigidities of the organs where metastasis was observed. We were able to abolish the
differential matrix rigidity response by knocking down Fyn kinase, which was previously identified as a critical component of
the FN rigidity response pathway in healthy cells. This result suggests possible molecular mechanisms of the rigidity
response in the malignant cells, indicating potential candidates for therapeutic interventions.
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Introduction
Metastases cause about 90% of deaths from solid tumors and
are very clinically diverse [1]. Metastasis occurs when cancer cells
adapt to the microenvironment of an organ distant from the
primary tumor and develop secondary tumors. Clinical observa-
tions indicate that certain organs are more susceptible to
metastases. The specificity of the tumors for particular distant
targets is known as tissue tropism. Although the first records of this
phenomenon date from the late 19
th century, the mechanisms and
molecular basis of tissue tropism are not fully understood. The
visionary ‘soil and seed’ hypothesis of metastasis was introduced in
1889 by Stephen Paget who postulated that sites of secondary
tumors are not randomly distributed throughout the body, and
that some organs provide a more fertile environment than others
for the growth of certain metastases [2]. Interestingly, this
hypothesis has not been widely accepted, until its revival in 1980
by Ian Hart and Isaiah Fidler [3].
A number of recent studies have focused on characterization of
genetic factors critical for tissue tropism of various tumors [4–9].
The most common target for breast cancer metastases is bone,
followed by lung, liver, and brain [10], and distinct gene
expression patterns have been associated with various metastases.
Regardless of the tissue tropism, all metastatic tumors undergo the
stage of dissemination to the regional lymph nodes. Through the
lymphatic system, malignant cells reach distant organs where they
can form secondary tumors. Biomechanical properties of the
surrounding tissues, such as matrix composition and rigidity, are
among the factors that govern this process. Despite numerous
studies, their precise role remains poorly understood.
To identify genes critical in tissue tropism, the Massague
laboratory used the MDA-MB231 breast cancer cell line, previously
identified as highly invasive, to derive a number of single cell
populations (SCPs) with different tumor target specificity [11]. The
model used to determine tissue tropic orientation of individual SCPs
involved injection of the cells in the cardiac ventricle, thereby
circumventing the stage of the regional lymph node metastasis. The
SCPs, isolated from the originally invasive line, displayed
differential tissue tropism and affinity for specific secondary targets
(lung, bone, adrenal glands) correlated with differential gene
expression patterns [12,13]. Interestingly, some of the SCPs have
shown a clear preference for either bone, or lung, while others
metastasized successfully to both target organs. Surprisingly, a
number of SCPs displayed no or very little metastatic potential.
Clusters of genes up/down-regulated in SCPs targeting a specific
organ have been identified. Intriguingly, one of genes upregulated
in bone-targeting SCPs was Fyn [12], a ubiquitously expressed Src-
family kinase. We have previously identified this kinase as a critical
signalling molecule in the fibronectin rigidity response in both
fibroblasts and neurons [14,15].
Here we report the differential rigidity response in various SCPs
isolated from MBA-MD231 breast cancer cell line. The matrix
rigidity selectively affected the cell proliferation and invasiveness in
various SCPs. It appears that SCPs display increased proliferation
and invasiveness in cases of matrix rigidity similar to the rigidity of
in vivo target organs.
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Rigidity Dependence of proliferation for SCPs correlates
with rigidity of the metastatic target
First, we tested whether proliferation of mammary control cells
(MCF10A, hereafter), and various SCPs was affected by matrix
rigidity. Cells were plated on collagen(Coll)-coated polyacrylamide
gels, and the viable, adherent cells were counted each 24 h over
the course of 72 h after plating (Fig. 1). As expected, the
proliferation rate of control mammary cells was increased on
rigid matrices compared to soft substrates. Further, SCPs
displayed differential proliferation depending on rigidity of the
matrix. The nonmetastatic SCPs, namely SCP21 and SCP26,
proliferated only on soft Coll-coated gels, while rigid substrates did
not support cell growth. The SCPs targeted specifically to the
bone, such as SCP2, SCP46, and SCP39, showed preferential
growth on rigid Coll-coated substrates, while soft substrates
inhibited their proliferation. Interestingly, the SCP with high
metastatic potential to both the bone and the lung, SCP28,
proliferated only on soft Coll-coated gels. This result was difficult
to interpret, and it could be explained by generally low
proliferation rates displayed by SCP28 indicating distinct regula-
tory mechanisms of growth in vitro versus in vivo conditions. The
SCPs that caused metastasis primarily in the lungs, but also, at
lower frequency, to the bone, SCP3 and SCP32, proliferated faster
on soft Coll-coated substrates than on rigid substrates. We
conclude that collagen rigidity response in various SCPs correlates
with the tissue tropism displayed in vivo.
Effect of the rigidity of fibronectin-coated substrates on
cell proliferation was similar to the effect of collagen
rigidity
To determine the effect of the ECM composition on mammary
cell proliferation, we tested proliferation of MCF10A cells and
various SCPs on FN-coated polyacrylamide gels. The experiments
were performed as in case of Coll-coated substrates, described
above. Proliferation rate of control MCF10A cells was increased
on rigid matrices, while being inhibited by soft FN-coated
substrates (Fig. 2). Similar to Coll-coated substrates, SCPs
proliferation rates were differentially affected by the rigidity of
the FN substrate. However, some differences were observed. First,
the nonmetastatic SCPs, SCP21 and SCP26, did not proliferate on
FN-coated gels, regardless of their rigidity. Surprisingly, SCP28,
characterized as highly metastatic to both target organs, displayed
no growth on FN-coated substrates. Similar to the behavior
observed on Coll-coated substrates, the SCPs targeted specifically
to the bone, (SCP2, SCP46, and SCP39), displayed preferential
growth on rigid FN-coated substrates, and proliferation was
inhibited on the soft substrates. Further, the SCPs targeting
primarily the lungs, and secondarily the bone, SCP3 and SCP32,
grew better on soft FN-coated substrates than on rigid substrates.
Fyn is required for rigid matrix-dependent proliferation
of bone-targeted SCPs
To test the role of the Fyn in the matrix rigidity response of
various SCPs, we used siRNA to knock down the expression of this
kinase in all of the previously tested lines. While silencing of Fyn
expression had no significant effect on proliferation of these cells
on collagen-coated matrices (data not shown), the effect on the
rigidity response on FN was striking (Fig. 3). Most importantly,
Fyn siRNA-treated SCPs normally associated with bone metasta-
sis, SCP2, SCP 46, and SCP39, lost their ability to proliferate on
rigid FN-coated matrices, and their proliferation on soft matrices
was also inhibited. The effect of Fyn siRNA on proliferation rate of
other SCPs was less prominent, but an overall inhibitory effect was
observed particularly on rigid surfaces. Importantly, lung-specific
SCPs, SCP3 and SCP32, maintained high proliferation rates on
the soft gels, despite the presence of Fyn siRNA. However, their
normaly low rates of proliferation on rigid FN were further
diminished. We speculate that the activity of Fyn kinase is required
for activating cancer cell growth on rigid fibronectin matrices.
The effect of 3-D matrix rigidity on cell invasiveness
correlates with the tissue tropism
The ability of the cancer cells to invade the surrounding tissues
is critical in the process of metastasis. To test the invasiveness of
the SCPs, we plated them on top of the 3-dimensional gels of
varying rigidities. The gels were reconstituted from Matrigel and
full-length fibronectin at the final concentration of 10 mg/ml
(Materials and methods). The number of cells that invaded after
48 h was counted (Fig. 4) and compared for various SCPs. As
expected, the control breast epithelial cells did not invade the gels
regardless of the rigidity. Rigidity did not affect the invasiveness of
the SCPs that preferably metastasized to the bone (SCP2, SCP46,
SCP39, and SCP28). These cell lines displayed high levels of
invasiveness regardless of the gel rigidity. The migration of SCPs
that metastasized to the lung (SCP3, SCP32) was impeded by
increasing gel rigidity. The cells lines that showed no metastatic
potential (SCP26, SCP28), invaded poorly even through the gels of
lowest rigidity. Therefore, we speculate that invasiveness of the
SCPs is correlated with the tissue tropism in vivo.
Early spreading events do not correlate with tissue
tropism in SCPs
Early cell spreading on ECM-coated glass has been used as a
model system for studying cell-ECM interactions [16], and it has
been correlated to metastatic potential in vivo [17]. Therefore, we
decided to quantify the effect of matrix rigidity on spreading of
SCPs. Cells were incubated on FN/Coll-coated gels as described
previously and their spread areas were quantified. Although we
observed statistically significant differences from control cells,
matrix rigidity did not appear to have an effect on spreading of
various SCP lines (Fig. 5). However, it was possible that spread area
reflected subtle differences in cell spreading processes that could
account for differential ability to proliferate on rigid matrices
displayedbybone-metastaticSCPs.Thus, welookedmore closelyat
the spreading process on FN-coated glass. The time course of the
early spreading events in representative cells (bone-specific SCP2,
lung-specific SCP3, non-metastatic SCP21, and control MCF10A
cells) was quantified (Figure 6). All SCPs exhibited high levels of
ruffling around the edges of protruding lamellipodia indicating
unstable focal complexes. However, all the cells spread relatively
quickly to their final area (20–30 min), which was followed by
periodic contractions. Interestingly, the metastatic lines displayed
slightlyincreased spreading velocitycompared tononmetastatic and
control lines. Cell spreading of SCPs was also tested on collagen-
coated glass, and no significant differences were observed (data not
shown). However, cell spreading on collagen was slower than
spreading on FN (1–2 h), confirming the differential effect matrix
had on cancer cell motility. Hence, we propose that cell spreading is
not a particularly good indicator of the differential motility,
proliferation, and invasiveness in the breast cancer cells.
Discussion
Cellular microenvironment is critical in the orchestration of
tumorogenesis and metastasis. Various factors present in the
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PLoS ONE | www.plosone.org 2 July 2009 | Volume 4 | Issue 7 | e6361Figure 1. Collagen rigidity differentially affects proliferation of the various SCPs. (A-D) Breast cancer cell lines SCP 2, SCP3, SCP21, and
breast epithelial cell lines MCF10A were plated on rigid and soft collagen-coated polyacrylamide gels and their proliferation was observed over the
time period of 72 h. (E) Representative morphology of SCP 2, SCP3, SCP21, and MCF10A cells after 72 h incubation on soft and rigid collagen-coated
gels. (F) Chart of the collagen rigidity response in SCP 2, SCP3, SCP21, SCP26, SCP28, SCP32, SCP39, SCP46, and breast epithelial cell line MCF10A and
their specific in vivo tissue tropisms.
doi:10.1371/journal.pone.0006361.g001
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PLoS ONE | www.plosone.org 3 July 2009 | Volume 4 | Issue 7 | e6361Figure 2. Fibronectin rigidity differentially affects proliferation of the various SCPs. (A-D) Breast cancer cell lines SCP 2, SCP3, SCP21, and
breast epithelial cell lines MCF10A were plated on rigid and soft FN-coated polyacrylamide gels and their proliferation was observed over the time
period of 72 h. (E) Representative morphology of SCP 2, SCP3, SCP21, and MCF10A cells after 72 h incubation on soft and rigid FN-coated gels (F)
Chart of the FN rigidity response in SCP 2, SCP3, SCP21, SCP26, SCP28, SCP32, SCP39, SCP46, and breast epithelial cell line MCF10A and their specific
in vivo tissue tropisms.
doi:10.1371/journal.pone.0006361.g002
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PLoS ONE | www.plosone.org 4 July 2009 | Volume 4 | Issue 7 | e6361Figure 3. Fyn is required for survival of bone-specific SCPs on rigid FN-coated matrices. (A-D) Breast cancer cell lines SCP 2, SCP3, SCP21,
and breast epithelial cell line MCF10A treated with Fyn siRNA were plated on rigid and soft FN-coated polyacrylamide gels and their proliferation was
observed over the time period of 72 h. (E) Representative morphology of Fyn siRNA-treated SCP 2, SCP3, SCP21, and MCF10A cells after 72 h
incubation on soft and rigid FN-coated gels (F) Chart of the effect of Fyn knockdown on the rigidity response in SCP 2, SCP3, SCP21, SCP26, SCP28,
SCP32, SCP39, SCP46, and breast epithelial cell line MCF10A. Their original in vivo tissue tropisms are also shown.
doi:10.1371/journal.pone.0006361.g003
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PLoS ONE | www.plosone.org 5 July 2009 | Volume 4 | Issue 7 | e6361Figure 4. Transwell migration of various SCPs in differentially dependent on matrix rigidity. (A) Transwell system used consists of the
upper chambers containg a thin layer of FN-enriched matrigel, perforated membrane, and the lower chamber coated with FN. (B-C) Breast cancer
cell lines SCP 2, SCP3, SCP21, SCP26, SCP28, SCP32, SCP39, SCP46, and breast epithelial cell lines MCF10A were plated in matrigel pf increasing
rigidities and their transwell migration rates were quantified after 48 h incubation.
doi:10.1371/journal.pone.0006361.g004
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PLoS ONE | www.plosone.org 6 July 2009 | Volume 4 | Issue 7 | e6361Figure 5. Matrix rigidity has no significant effect on spreading areas of the SCPs. (A-B) Breast cancer cell lines SCP 2, SCP3, SCP21, SCP26,
SCP28, SCP32, SCP39, SCP46, and breast epithelial cell line MCF10A were allowed to spread on rigid and soft collagen-coated (A) or FN-coated (B)
polyacrylamide gels for 2 h, when the spreading areas were quantified.
doi:10.1371/journal.pone.0006361.g005
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PLoS ONE | www.plosone.org 7 July 2009 | Volume 4 | Issue 7 | e6361Figure 6. Early spreading motility appears uniform among different SCPs. (A-D) Breast epithelial cell line MCF10A (A), and breast cancer
cell lines SCP 2 (B), SCP3 (C), and SCP21 (D) were plated on FN-coated glass and their spreading was recorded. The timecourse of representative cells
is shown. No significant changes in cell area or motility were observed in cells that were observed longer than 20 min (up to 2 h). (E) Time
dependence of the avareage spread area in SCP 2, SCP3, SCP21, and MCF10A cells. (F) Average spreading rates were calculated for 5 min time
periods to quantify early spreading velocities in SCP 2, SCP3, SCP21, and MCF10A cells.
doi:10.1371/journal.pone.0006361.g006
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PLoS ONE | www.plosone.org 8 July 2009 | Volume 4 | Issue 7 | e6361microenvironment, such as growth factor concentrations, homing
receptors, matrix components, and mechanical properties of the
matrix, have been shown to affect tumor growth and metastasis
[18]. In this study, we focused on the effect of the mechanical
rigidity of the ECM on proliferation and invasiveness of the breast
cancer cells.
Mechanosensing is involved in cell motility, matrix remodeling,
and development, as well as in a number of pathological processes,
such as tumor formation and metastasis [19]. The rigidity of the
extracellular matrix is one of the critical properties of the ECM
and different cell types respond to matrix rigidity in fundamentally
different ways [20]. The specific matrix rigidity requirements in
different cell types have been correlated with the rigidities of their
native tissues in vivo [21]. In addition, the differentiation of the
stem cells through changes in gene expression was shown to
depend on matrix rigidity [22]. Application of external mechanical
force enhances integrin clustering and the subsequent recruitment
of focal contact proteins, that, in turn, associate with the actin
cytoskeleton and activate multiple signaling proteins including
focal adhesion kinase (FAK), Src family kinases, Rho GTPase, and
integrin-linked kinase (ILK), to promote cell growth, migration,
and differentiation [23,24]. In addition to the overall rigidity
response being altered in malignantly transformed cells in vitro
[25], similar behavior was described in vivo [26,27] further
emphasizing the relevance of proper mechanosignaling to complex
processes such as differentiation, development, migration, and
regeneration.
Interactions between epithelial cells and the extracellular matrix
(ECM) regulate mammary gland development, and are critical for
the maintenance of tissue homeostasis. The extracellular matrix
regulates growth, survival, migration, and differentiation through a
variety of transmembrane receptors. Similar to breast develop-
ment, malignant transformation of the breast is also associated
with significant alterations in ECM composition, turnover,
processing, and orientation [24]. Intriguingly, certain epithelial
cancers can be induced to regenerate normal tissue morphology
when presented with embryonic mesenchyme or exogenous ECM
scaffolds [18]. The upregulation of ECM genes has not only been
detected in tumors, but has also been associated with poor
prognosis [28]. In addition, cancer progression is characterized by
extensive matrix remodeling and progressive stiffening of the
stroma, which affects epithelial-stromal interactions, that could in-
turn enhance epithelial cell growth, affect breast tissue organiza-
tion, and promote cell invasion and survival. While the ECM in
the normal breast is soft, the increased rigidity of the matrix,
characteristic of malignant transformation, or externally applied
force, stimulated proliferation and promoted a tumor-like behavior
in mammary cells [25]. Furthermore, altered expression of b1-,
b4-, a2-, a3- and a6-integrins has been reported in breast cancer
cells [29].
In this study, we demonstrated a differential rigidity response in
the single cell populations (SCPs) derived from a highly invasive
breast cancer cell line MDA-MB231. These SCPs displayed
differential metastatic potential and tissue tropism in vivo, which
were correlated with different patterns of gene expression [12,13].
Based on these profiles, SCPs displayed clustering in three groups
that corresponded to their metastatic potential: bone, lung, or non-
metastatic group. A few of these lines were also reported to cause
adrenal gland metastases. Due to the intrinsic limitation of the
animal model, no lines specifically targeting the brain or regional
lymph nodes were isolated. As expected, different SCP clusters
(bone-targeting, lung-targeting, and non-metastatic) showed dif-
ferential rigidity responses on both collagen and fibronectin. While
soft collagen matrices promoted proliferation of the lung-targeting
and non-metastatic SCPs, rigid matrices inhibited growth of lung-
targeting and non-metastatic lines, while promoting proliferation
of bone-targeting SCPs. The effect of FN rigidity was even more
pronounced, since most lines did not proliferate on FN-coated
matrices, except bone-targeting lines that grew rapidly on rigid
FN-coated gels. This observation can be correlated with the
differences in the rigidity of the target tissues, which can have an
effect on cell proliferation in vivo. Further, we showed that the
ability of bone-targeting SCPs to proliferate on rigid matrices was
critically dependent on activity of Fyn kinase, which has been
previously detected as upregulated in these SCPs [12,13]. This is
interesting, especially in the light of our previous reports showing
that Fyn kinase was indispensable in fibronectin rigidity sensing in
fibroblasts and neurons [14,15]. One can speculate that some of
the rigidity pathways employed by healthy cells, can be misused in
malignant cells. Next, we showed that the matrix rigidity affects
the SCP’s motility and invasiveness in the 3-D environment as
well. Only bone-targeting lines were successful in migration
through rigid matrigels, while lung-targeting SCPs invaded only
through soft matrices, and non-metastatic lines showed no ability
to invade. We speculate that matrix rigidity might similarly affect
the cell invasiveness in vivo, which needs to be confirmed in the
future studies. Finally, we are unable to detect any differences in
early cell spreading and immediate rigidity response among
various SCPs. This result can be interpreted by the differential
effect that mechanical properties of the matrix have on cell
spreading versus proliferation and invasiveness in transformed
cells. Importantly, this study confirms the similarities between
behavior of cancer cells in artificial matrix models and in the
whole animal environment. Therefore, these systems could be
used to further elucidate rigidity response mechanisms in cancer
cells and potentially modulate these to develop novel diagnostic
tools and therapeutic approaches.
Materials and Methods
Cell culture
MCF10A human breast epithelial cells and malignant SCPs
isolated from MDA-MB-231 breast cancer line were generous gift
from Professor Joan Massague. MCF10A cels were grown in 1:1
mixture of DMEM and Ham’s F-12 media supplemented with 5%
Horse Serum, 100 mg/mL streptomycin, 2 mM L-glutamine, and
20 mM HEPES, 10 mg/ml insulin, 0.5 mg/ml hydrocortisone and
0.02 mg/ml EGF (all materials from Invitrogen). SCP cell lines
were grown in high glucose DMEM supplemented with 10% Fetal
Bovine Serum, 100 units/mL penicillin, 100 mg/mL streptomy-
cin, 2 mM L-glutamine, and 20 mM HEPES.
Spreading assays on polyacrylamide substrates
The full-length fibronectin (FN) or collagen (Coll)-coated
polyacrylamide substrates were prepared as described previously
[30]. The flexibility of the substrate was manipulated by
maintaining the total acrylamide concentration at 5% while
varying the bis-acrylamide component between 0.08% (rigid) and
0.03% (soft) (E=3kPa, and E=600Pa, respectively) [31]. The
uniformity of ECM coating on the substrate surface was examined
by coating the gels with FN/Coll conjugated to Cy5 fluorophore
(Amersham Biosciences) according to manufacturer’s instructions
and visualized by confocal microscopy. Experiments were
performed 2 h after the cells were plated on the polyacrylamide
gels at a low density. Spread area was quantified for at least 50
cells for each condition and statistical significance of the results
confirmed by t-test (p,0.01). Data is presented as mean6standard
error.
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Silencer
TM siRNA transfection kit and custom siRNAs sequences
targeted against Fyn (Ambion) were used according to manufac-
turer’s protocol. The Fyn expression levels were tested by
immunofluorescent staining with anti-Fyn (Chemicon) antibody.
Controls with ‘‘scrambled’’ siRNA sequences were included.
Antibodies
For this study, the following antibodies were used: a mouse
monoclonal antibody against Fyn (Chemicon), an affinity purified
polyclonal rabbit anti-phoshoY165Cas antibody (Cell Signaling
Technology), HRP-conjugated anti-mouse and anti-rabbit anti-
bodies (Amersham), an affinity purified rabbit polyclonal phos-
phoY416-Src kinase family antibody (Cell Signaling Technology),
a goat anti-rabbit Ig conjugated with Alexa 647 (Molecular
Probes), a goat anti-rabbit Ig conjugated with Alexa 555
(Molecular Probes), and goat anti-mouse Ig conjugated with Alexa
568 (Molecular Probes).
Spreading assays on FN-coated glass
The glass coverslips were coated with 10 mg/ml full-length
fibronectin (FN) for 1 h at 37uC. The cells were trypsynized,
resuspended in serum-free DMEM media, incubated at 37uC, and
then plated on FN-coated glass. Cell spreading was recorded for
30 minutes with a cooled CCD camera attached to an Olympus
IX81 equipped with a 106objective.
Invasion assays
Gels were polymerized in the upper chamber of the transwells
with polyester 8 mm-perforation membranes (Corning) (Fig. 3). By
varying concentrations of Matrigel (BD Biosciences), that was
reconstituted according to manufacturer’s instructions at final
concentrations of 2 mg/ml, 3 mg/ml, and 4 mg/ml, we obtained
gels of varying rigidities. The full-length FN was added to the gels
prior to the polymerization at the final concentration of 10 mg/ml.
The bottom of the lower chamber was coated with 10 mg/ml FN
to facilitate the adhesion of the invaded cells. Cells were plated on
top of the gels, and cultured for 48 h, then fixed with 5%
glutaraldehyde, and stained with toluidine blue to visualize the
invaded cells. The number of invaded cells was counted using 20X
objective. The minimum of 5 representative fields was counted for
each condition [32].
Immunocytochemistry
Mammary cells were plated onto FN/Coll-coated coverglasses
(10 mg/mL FN/Coll) or FN/Coll-coated polyacrylamide gels.
After incubation for the described time, cells were fixed in 3.7%
formaldehyde and permeabilized with 0.1% Triton. Fixed cells
were incubated with primary antibodies (described above) for 1 h
followed by washing and incubation with appropriate fluorescent
secondary antibodies (also described above). Fluorescent signals
from all samples were visualized by confocal microscopy.
Microscopy and analysis
Images of immunofluorescently stained samples were acquired
using a Fluoview confocal microscope (Olympus, Melville, NY).
Phase contrast images of the cells plated on polyacrylamide
substrates were recorded with a cooled CCD camera attached to
an Olympus IX81 equipped with a 106 objective. Analysis of
acquired images was performed with the image analysis program,
ImageJ (by W. Rasband (NIH, Bethesda, MD http://rsb.info.nih.
gov/ImageJ).
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